Searchable abstracts of presentations at key conferences in endocrinology

ea0070aep1080 | Hot topics (including COVID-19) | ECE2020

Gender differences of growth hormone and insulin-like growth factor-1 in patients with acromegaly after radiation therapy

Issaeva Saodat , Khalimova Zamira , Kholikova Adliya , Safarova Shokhsanam

Purpose of the study: To determine the gender differences in growth hormone (GH) and insulin-like growth factor-1 (IGF-1) in patients with somatotropic pituitary adenomas after radiation therapy (RT).Materials and research methods: The object of the study is 94 patients with acromegaly receiving RT in a total dose of 45–50 gray. Of these, 26 (27.7%) are men and 68 (72.3%) are women. The peak manifestation of acromegaly in the total sample was in th...

ea0070ep544 | Hot topics (including COVID-19) | ECE2020

Frequency of musculoskeletal complications in patients with acromegaly in the Ferghana Valley

Safarova Shokhsanam , Khalimova Zamira , Kholikova Adliya , Issaeva Saodat

The aim of the study was to study the incidence of osteo-articular complications in patients with acromegaly in the Ferghana Valley.Materials and methods: 129 patients with acromegaly in the Ferghana Valley who were included in the national register of acromegaly were examined. Of these, men – 46 (35.7%), women – 83 (64.3%). The average age of the patients was (48 ± 8.7 years). By age, patients were divided into three groups: 1 group &#8...

ea0070ep575 | Hot topics (including COVID-19) | ECE2020

Clinical manifestations of musculoskeletal complications of acromegaly

Safarova Shokhsanam , Khalimova Zamira , Kholikova Adliya , Issaeva Saodat

Summary: Objective: To study the clinical manifestations of musculoskeletal complications (MSC) of acromegaly, to improve the early diagnosis of the disease.Materials and methods: 150 patients with acromegaly were examined who were observed at the RSSPMC of Endocrinology during the period from 2000 to 2020. The age of patients ranged from 19 to 76 years and averaged 43 ± 8.6 years. Of these, 65 (43.3%) were men and 85 (56.7%) women. Moreover, the du...

ea0022p572 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Comparison of different therapy approaches in acromegaly

Khalimova Zamira , Kholikova Adliya , Urmanova Yulduz , Alieva Dinara , Nasirova Khurshida , Alimukhamedova Gulrukh , Murtazaeva Liliya , Safarova Shokhsanam

Aim of the research: To study relationship between GH levels and acromegaly complications development in different therapy approaches.Patients and methods: We evaluated 50 patients with GH secreting adenomas referred to CCSSE from 1999 to 2004. Age of patients was from 19 to 63 years-old (mean age 40±19 years-old). Duration of the disease was from 1 to 23 years.Methods: Clinical and biochemical tests of neurological status; RI...

ea0022p573 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Clinical and epidemiologic features of acromegaly in the Republic of Uzbekistan

Khalimova Zamira , Kholikova Adliya , Urmanova Yulduz , Alieva Dinara , Narimova Gulchekhra , Safarova Shokhsanam , Nasirova Khurshida , Alimukhamedova Gulrukh

Aim of the research: To study clinical and epidemiologic features of acromegaly in the Republic of Uzbekistan.Patients and methods: We observed acromegalic patients registered from 2007 to 2009 who are dispensarized in the regions of the country. Of the 369 patients 143 were males (38.7%) and 226 females (61.3%). Mean age of the patients was 42.6 years-old. Duration of the disease varied from 1 to 31 years.Results: According to the...

ea0022p581 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

The rate of vascular complications in acromegaly in the Republic of Uzbekistan

Khalimova Zamira , Kholikova Adliya , Salakhova Nazira , Urmanova Yulduz , Alieva Dinara , Nasirova Khurshida , Narimova Gulchekhra , Safarova Shokhsanam

Aim of the research: To study the rate of vascular complications in acromegaly in the Republic of Uzbekistan.Patients and methods: We observed acromegalic patients registered from 2007 to 2009 who are dispensarized in the regions of the country. Of the 369 patients 143 were males (38.7%) and 226 females (61.3%). Mean age of the patients was 42.6 years-old. Duration of the disease varied from 1 to 31 years.Results: We assessed the r...

ea0022p582 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Long and short-term therapy effectiveness with dopamine agonists in acromegaly in the Republic of Uzbekistan

Ismailov Said , Khalimova Zamira , Kholikova Adliya , Urmanova Yulduz , Murtazaeva Liliya , Alieva Dinara , Nasirova Khurshida , Alimukhamedova Gulrukh

Aim of the research: To study long and short-term therapy effectiveness with dopamine agonists in acromegaly.Patients and methods: Three hundred and sixty-nine patients with acromegaly registered by December, 1 2009 in the Republic of Uzbekistan. Of these patients we observed 20 cases with GH-secreting pituitary adenoma. Age of the patients was from 19 to 63 years-old (mean age 40±19 years-old), duration of the disease was from 1 to 23 years. Patien...